论文部分内容阅读
目的观察卡前列素氨丁三醇注射液预防产后出血的临床疗效。方法将104例具有宫缩乏力性产后出血高危因素的产妇按照随机数字表法分为试验组和对照组各52例。比较2组产后出血率和产后2h、24h出血量及不良反应发生情况、治疗满意度。结果试验组产后出血率为3.8%(2/52)明显低于对照组的19.2%(10/52),差异有统计学意义(P<0.05)。试验组患者产后2h出血量、产后24h出血量均少于对照组,差异有统计学意义(P<0.05)。试验组总不良反应发生率为9.6%(5/52)明显低于对照组的30.8%(16/52),差异有统计学意义(P<0.05)。试验组患者治疗满意度为98.1%(51/52)明显高于对照组的80.8%(42/52),差异有统计学意义(P<0.05)。结论采用卡前列素氨丁三醇注射液预防宫缩乏力性产后出血,可获得较好的临床效果,减少产后2h、24h出血量,且不良反应少,安全可靠,值得进行深入研究和推广。
Objective To observe the clinical efficacy of carboprost trometamol injection in preventing postpartum hemorrhage. Methods 104 cases of women with uterine inertia at risk of postpartum hemorrhage were randomly divided into experimental group and control group of 52 cases. The incidence of postpartum hemorrhage, postpartum hemorrhage, and the incidence of adverse reactions at 2h and 24h postpartum were compared between two groups. The treatment satisfaction was compared. Results The rate of postpartum hemorrhage in the experimental group was 3.8% (2/52), which was significantly lower than that in the control group (19.2%, 10/52). The difference was statistically significant (P <0.05). The amount of hemorrhage 2 hours after delivery and the amount of hemorrhage 24 hours after delivery in the experimental group were all less than those in the control group, with significant difference (P <0.05). The total incidence of adverse reactions in the experimental group was 9.6% (5/52), which was significantly lower than that in the control group (30.8%, 16/52). The difference was statistically significant (P <0.05). The satisfaction rate of patients in the experimental group was 98.1% (51/52), which was significantly higher than that of the control group (80.8%, 42/52). The difference was statistically significant (P <0.05). Conclusion The use of carboprost trometamol injection to prevent uterine atony postpartum hemorrhage, get better clinical results, reduce postpartum 2h, 24h blood loss, and less adverse reactions, safe and reliable, it is worth carrying out in-depth study and promotion.